Richard Lafayette

Publication Details

  • Imatinib in the treatment of nephrogenic systemic fibrosis.

    Chandran S, Petersen J, Jacobs C, Fiorentino D, Doeden K, Lafayette RA. Am J Kidney Dis. 2009; 53 (1): 129-32

    Nephrogenic systemic fibrosis is a disabling progressive condition that is being reported with increased frequency in patients with kidney disease. Treatment is extremely limited and largely supportive. We report a case of severe nephrogenic systemic fibrosis in a dialysis patient exposed to multiple doses of gadolinium who improved clinically and histologically with treatment with imatinib.

    PubMedID: 19012999

Stanford Medicine Resources:

Footer Links: